Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 2601 South Bayshore Drive, Suite 900 MIAMI FL 33133 |
Tel: | N/A |
Website: | https://www.ayrwellness.com |
IR: | See website |
Key People | ||
Jonathan E. Sandelman Executive Chairman of the Board | David Goubert President, Chief Executive Officer | Brad Asher Chief Financial Officer |
Jason Griffith Chief Operating Officer | Robert Mendola Head of Strategy and M&A |
Business Overview |
AYR Wellness Inc. is a vertically integrated multi-state cannabis operator in the United States. The Company operates simultaneously as a retailer with more than 90 licensed dispensaries and a house of cannabis consumer packed goods (CPG) brands. It is a cultivator, manufacturer and retailer of cannabis products and branded CPG, and is engaged in the manufacture, possession, use, sale, or distribution of cannabis and/or holds licenses in the adult-use and/or medicinal cannabis marketplace in the States of Massachusetts, Nevada, Pennsylvania, Florida, New Jersey, Ohio, Illinois, and Connecticut. The Company's portfolio of CPG brands includes Kynd, Origyn Extracts, Levia, STiX Preroll Co., Secret Orchard, and Entourage, among others. It owns and operates a chain of cannabis retail stores under various brand names. The Company distributes and markets its products to Company-owned retail stores and to third-party licensed retail cannabis stores throughout its operating footprint. |
Financial Overview |
For the fiscal year ended 31 December 2023, Ayr Wellness Inc revenues increased 10% to $463.6M. Net loss before extraordinary items decreased 58% to $86.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Impairment of goodwill decrease of 95% to $6.3M (expense), General and administrative - Balanci decrease of 19% to $161.2M (expense). |
Employees: | 2,300 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $905.27M as of Dec 31, 2023 |
Annual revenue (TTM): | $635.17M as of Dec 31, 2023 |
EBITDA (TTM): | $133.60M as of Dec 31, 2023 |
Net annual income (TTM): | -$117.93M as of Dec 31, 2023 |
Free cash flow (TTM): | $1.86M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $563.74M as of Dec 31, 2023 |
Shares outstanding: | 114,697,656 as of Apr 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |